Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2023-07-28 00:00:00 ET · period of report 2023-07-26 · accession 0001104659-23-085497 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-28 | 2023-07-26 | RYTM | Cramer Pamela J. | CHRO | S - Sale+OE | $17.64 | -930 | 8,418 | -10% | -$16.4K |
| D | 2023-07-28 | 2023-07-26 | RYTM | Cramer Pamela J. | CHRO | M - OptEx | — | +3,125 | 9,348 | +50% | — |
| D | 2023-07-28 | 2023-07-26 | RYTM | Cramer Pamela J. | CHRO | M - OptEx | $0.00 | -3,125 | 6,250 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-26 | S | D | 930 | $17.64 | 8,418 | D | — | — | |
| 2 | Common | Common Stock | 2023-07-26 | M | A | 3,125 | — | 9,348 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F2) Includes 81 shares acquired under Issuer's Employee Stock Purchase Plan on February 28, 2023. |
| 3 | Derivative | Restricted Stock Units | 2023-07-26 | M | D | 3,125 | $0.00 | 6,250 | D | — · — to — | 3,125 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F4) The restricted stock units vest or have vested as to 25% of the total shares on each of July 26, 2022, July 26, 2023, July 26, 2024 and July 26, 2025. The restricted stock units have no expiration date. |